Differentiating high-grade glioma progression from treatment-related changes with dynamic [F]FDOPA PET: a multicentric study.
Fiche publication
Date publication
novembre 2022
Journal
European radiology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr TAILLANDIER Luc, Pr VERGER Antoine, Dr RECH Fabien
Tous les auteurs :
Rozenblum L, Zaragori T, Tran S, Morales-Martinez A, Taillandier L, Blonski M, Rech F, Galanaud D, Kas A, Verger A
Lien Pubmed
Résumé
Diagnostic accuracy of amino-acid PET for distinguishing progression from treatment-related changes (TRC) is currently based on single-center non-homogeneous glioma populations. Our study assesses the diagnostic value of static and dynamic [F]FDOPA PET acquisitions to differentiate between high-grade glioma (HGG) recurrence and TRC in a large cohort sourced from two independent nuclear medicine centers.
Mots clés
Dynamic analysis, Glioma, PET, Recurrence, [18F]FDOPA
Référence
Eur Radiol. 2022 11 11;: